ask why

Latest research

Every new paper in 280 characters, with how strong the evidence is and what readers question about it. Free to read.

Sleep medicine · Sleep Med Rev · 2026-08-27

Network meta-analysis of 33 RCTs (5045 hospitalised patients): melatonin/melatonin receptor agonists (RR 0.77) and suvorexant (RR 0.51) were associated with lower delirium risk vs non-active control; midazolam showed no significant reduction (RR 1.64). Low–moderate certainty.

Meta-analysisn = 5,045
Chen et al. Sleep-modulating pharmacological interventions for delirium prevention: a systematic review and a network meta-analysis of randomized controlled trials
Sleep medicine · Sleep Med Rev · 2026-07-10

Network meta-analysis of 98 RCTs (28,920 people with chronic non-cancer pain): melatonin improved sleep quality vs placebo (SMD -0.60; moderate certainty) without raised adverse events; ten other agents helped sleep but with low-certainty evidence and more adverse events.

Meta-analysisn = 28,920
Chang et al. Comparative effectiveness and safety of pharmacological interventions for sleep outcomes in chronic non-cancer pain: a systematic review and network meta-analysis
Anaesthesia and pain · Pain · 2026-06-30

Systematic review of 23 RCTs (2028 participants): in chronic musculoskeletal pain, melatonin did not significantly reduce pain vs placebo (MD −6.76/100, 95% CI −15.89 to 2.36) but beat active controls (MD −11.21/100); low-to-moderate certainty, mostly below MCID.

Meta-analysisn = 2,028
Wu et al. Efficacy and effectiveness of melatonin for the management of musculoskeletal pain: a systematic review and meta-analysis of placebo and active controlled trials

Sign in to react

Enter your email and we send a 6-digit code and a link. No password.

Your name and role

These appear beside any methods concern you post and on your profile page.